Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Diffusion Pharmaceuticals Inc. | Financial_Report.xls |
EX-4.6 - EX-4.6 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex4d6.htm |
EX-4.4 - EX-4.4 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex4d4.htm |
EX-4.5 - EX-4.5 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex4d5.htm |
EX-31.1 - EX-31.1 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex31d1.htm |
EX-32.2 - EX-32.2 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex32d2.htm |
EX-21.1 - EX-21.1 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex21d1.htm |
EX-32.1 - EX-32.1 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex32d1.htm |
EX-10.12 - EX-10.12 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex10d12.htm |
EX-10.13 - EX-10.13 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex10d13.htm |
10-K - 10-K - Diffusion Pharmaceuticals Inc. | a15-2678_110k.htm |
EX-31.2 - EX-31.2 - Diffusion Pharmaceuticals Inc. | a15-2678_1ex31d2.htm |
Exhibit 10.7
April 23, 2014
Dear Mr. Rubinstein,
This letter serves as a formal agreement between RestorGenex (formerly Stratus Media Group) and yourself regarding board of directors fees earned by you during your service as a director. This will confirm that you have agreed to accept the following sums as all amounts due and owing to you for all service as a board member and employee excluding stock and cash owed to you as director only since January 1, 2014:
· Cash: $100,000 (to be paid upon the closing of $7.5MM in funding); and
· $150,000 (to be paid within 4 months of closing $7.5MM in funding)
· Common stock: 1,250 shares
Please sign below. Please let me know if you have any questions. Thank you.
Sincerely,
/s/ Tim Boris |
|
|
Tim Boris |
|
|
General Counsel |
|
|
RestorGenex Corporation |
|
|
|
|
/s/ Jerold Rubinstein |
|
|
Jerold Rubinstein |